To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling

scientific article

To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2010PLoSO...511284L
P356DOI10.1371/JOURNAL.PONE.0011284
P932PMC publication ID2890406
P698PubMed publication ID20585642
P5875ResearchGate publication ID44807336

P50authorKenneth J SmithQ43175898
Richard ZimmermanQ42658961
Ann E WiringaQ56774930
Rachel B. SlaytonQ56774942
Bruce Y. LeeQ65555428
Sarah M McGloneQ106457677
Shanta M ZimmerQ114338917
P2860cites workProbabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux diseaseQ44084354
Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United StatesQ44276981
Performance characteristics of clinical diagnosis, a clinical decision rule, and a rapid influenza test in the detection of influenza infection in a community sample of adultsQ44841385
Diagnosing influenza--clinical assessment and/or rapid antigen testing?Q45052229
Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009.Q45382219
Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humansQ45383194
Treat or test first? Decision analysis of empirical antiviral treatment of influenza virus infection versus treatment based on rapid test results.Q45731703
Cost-effectiveness of treating influenzalike illness with oseltamivir in the United StatesQ45810645
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of AmericaQ48585293
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.Q48719424
Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.Q50754705
Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses.Q54479219
Does This Patient Have Influenza?Q22252995
Neuraminidase inhibitors for preventing and treating influenza in healthy adultsQ24244898
Vaccines for preventing influenza in the elderlyQ24245325
Vaccines for preventing influenza in healthy adultsQ24246585
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysisQ24644585
Antivirals for influenza in healthy adults: systematic review.Q30352729
Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK.Q30353815
Antivirals and influenza: frequency of resistance.Q30372305
Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1.Q30380340
Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trialQ31931976
Influenza outbreak during Sydney World Youth Day 2008: the utility of laboratory testing and case definitions on mass gathering outbreak containmentQ33499697
Influenza virus resistance to antiviral agents: a plea for rational use.Q33701528
One thousand health-related quality-of-life estimatesQ33937445
Cost-effectiveness of newer treatment strategies for influenzaQ33961752
Prevention and treatment of influenzaQ34103251
Influenza. Cost of illness and considerations in the economic evaluation of new and emerging therapiesQ34219687
Neuraminidase inhibitors for influenzaQ34455162
Management of influenza symptoms in healthy adultsQ34742405
Prevalence and seasonality of influenza-like illness in children, Nicaragua, 2005-2007Q37189492
The impact of influenza on working days lost: a review of the literatureQ37292575
Cost effectiveness of oseltamivir treatment of influenza: a critique of published methods and outcomesQ37486665
Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenzaQ40596066
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study GroupQ40625504
Low sensitivity of rapid diagnostic test for influenza.Q54489183
Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreakQ57099517
The utility of different health states as perceived by the general publicQ67429353
Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in AustraliaQ74287490
Toward consistency in cost-utility analyses: using national measures to create condition-specific valuesQ74660492
How sensitive are cost-effectiveness analyses to choice of parametric distributions?Q80977056
Cost-effectiveness of universal influenza vaccination in a pregnant populationQ83886549
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)e11284
P577publication date2010-06-23
P1433published inPLOS OneQ564954
P1476titleTo test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling
P478volume5

Reverse relations

cites work (P2860)
Q30235281A Narrative Review of Influenza: A Seasonal and Pandemic Disease
Q36215695An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine.
Q50069031Automated influenza case detection for public health surveillance and clinical diagnosis using dynamic influenza prevalence method.
Q92381089Cost-Effective Respiratory Virus Testing
Q36559794Cost-effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point-of-care rapid test versus clinical judgment.
Q40713908Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly
Q40105670Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting
Q49989122Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics.
Q34171619Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients.
Q93537719Current Best Practices for Respiratory Virus Testing
Q30353587Influenza testing, diagnosis, and treatment in the emergency department in 2009-2010 and 2010-2011
Q30398368Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics.
Q36434424Performance of a Novel Point-of-Care Molecular Assay for Detection of Influenza A and B Viruses and Respiratory Syncytial Virus (Enigma MiniLab) in Children with Acute Respiratory Infection.
Q36231674Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.
Q37147720Prevention of influenza in healthy children
Q30410029Rethinking approaches to improve the utilization of nucleic acid amplification tests for detection and characterization of influenza A in diagnostic and reference laboratories
Q34111130Socioeconomic impact of seasonal (epidemic) influenza and the role of over-the-counter medicines
Q28481328Systematic review of economic evaluations of preparedness strategies and interventions against influenza pandemics
Q30398941The 2009 H1N1 influenza pandemic: a case study of how modeling can assist all stages of vaccine decision-making
Q35652153The cost of an Ebola case
Q29587258The potential economic burden of Zika in the continental United States
Q90177670Utility of Rapid Influenza Molecular Testing in an Outpatient Hemodialysis Unit: A Prospective Cohort Study

Search more.